List of insiders holdings for BELLICUM PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | BAKER BROS. ADVISORS LP BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC 10% Owner |
2023-11-24 13:43:27 | 2,365,472 0 |
2,365,472 | Form 13D |
| 2 | McGuyer Investments Ltd. 10% Owner |
2014-12-23 16:29:31 | 2,260,133 0 |
2,260,133 | Form 4 |
| 3 | Remeditex Ventures LLC 10% Owner |
2014-12-23 16:25:28 | 1,851,166 0 |
1,851,166 | Form 4 |
| 4 | Fair Richard A. President and CEO |
2022-08-16 17:04:29 | 400,000 0 |
400,000 | Form 4 |
| 5 | Scripture Charity Chief Development Officer |
2022-08-16 17:04:47 | 250,000 0 |
250,000 | Form 4 |
| 6 | Stonehouse Jon P Director |
2023-01-05 13:11:55 | 204,086 0 |
204,086 | Form 4 |
| 7 | Huber Reid M Director |
2023-01-20 14:24:51 | 146,951 0 |
146,951 | Form 4/A |
| 8 | DAVIS STEPHEN Director |
2023-01-05 13:12:31 | 136,854 0 |
136,854 | Form 4 |
| 9 | Klimovsky Judith V Director |
2023-01-05 13:04:50 | 110,098 0 |
110,098 | Form 4 |
| 10 | Daly James M Director |
2023-01-05 13:12:48 | 109,873 0 |
109,873 | Form 4 |
| 11 | Farrell Thomas J. President and CEO |
2017-01-05 19:14:53 | 75,250 0 |
75,250 | Form 4 |
| 12 | Musso Alan A CFO and Treasurer |
2018-07-05 16:03:57 | 52,500 0 |
52,500 | Form 4 |
| 13 | Strauss David Eric Sr Director, Corp Controller |
2020-12-16 13:55:31 | 35,000 0 |
35,000 | Form 4 |
| 14 | BROWN JAMES F Director |
2022-01-06 09:49:40 | 28,384 0 |
28,384 | Form 4 |
| 15 | Moseley Annemarie COO/EVP Clinical Development |
2017-01-05 19:15:43 | 28,000 0 |
28,000 | Form 4 |
| 16 | Grossman William Sr. VP, Chief Medical Officer |
2019-02-07 16:02:03 | 26,874 0 |
26,874 | Form 4 |
| 17 | HARRIGAN EDMUND Director |
2019-06-14 16:05:25 | 25,000 0 |
25,000 | Form 4 |
| 18 | Smith Alan K. EVP, Technical Operations |
2020-04-09 14:41:41 | 22,307 0 |
22,307 | Form 4 |
| 19 | Mokari Atabak Chief Financial Officer |
2020-04-09 14:42:58 | 21,792 0 |
21,792 | Form 4 |
| 20 | Senesac Joseph VP of Manufacturing |
2015-02-26 18:33:20 | 20,000 0 |
20,000 | Form 4 |
| 21 | Foster Aaron E. Sr VP, Head of Research |
2020-04-09 14:44:11 | 19,517 0 |
19,517 | Form 4 |
| 22 | Hoang Peter L. Sr. VP of Bus. Development |
2017-01-05 19:18:03 | 17,500 0 |
17,500 | Form 4 |
| 23 | Spencer David M. Chief Technology Officer |
2019-02-05 16:10:56 | 15,000 0 |
15,000 | Form 4 |
| 24 | Naeve Gregory S. Chief Business Officer |
2019-08-23 16:04:17 | 13,746 0 |
13,746 | Form 4 |
| 25 | Woodard Jr Joseph Paul SVP Clinical & Medical Affairs |
2019-11-14 17:11:12 | 12,967 0 |
12,967 | Form 4 |
| 26 | McGuyer Frank B. Director |
2018-06-18 16:33:28 | 10,000 0 |
10,000 | Form 4 |
| 27 | Slawin Kevin M. Director |
2017-06-15 16:43:12 | 10,000 0 |
10,000 | Form 4 |
| 28 | Williams Rosemary Y. VP, Finance & PAO |
2020-01-06 17:15:26 | 9,099 0 |
9,099 | Form 4 |
| 29 | Moseley Ken Sr. VP and General Counsel |
2018-01-05 16:03:18 | 6,152 2,193 |
8,345 | Form 4 |
| 30 | Ward Shane Sr VP and Chief Legal SO |
2020-06-02 12:25:24 | 1,879 0 |
1,879 | Form 4 |
| 31 | Grass Charles S. Principal Accounting Officer |
2021-05-17 17:34:14 | 0 0 |
0 | Form 3 |